Rare diseases
Investigational molecules
Locations
Calle De Velazquez 7 Planta 3, 28001 Madrid, Spain
Research activity includes advanced radioactive-iodine-refractory differentiated thyroid carcinoma and anaplastic thyroid carcinoma, with interest in therapies directed at TROP-2 and cabozantinib in thyroid cancer.
The sponsor also supports work on predictive blood-based markers and treatment response assessment in advanced thyroid malignancies.
Grupo Espanol De Tumores Neuroendocrinos runs clinical trials in conditions such as Neuroendocrine carcinoma, Small intestine neuroendocrine tumour, Anaplastic thyroid cancer, Neuroendocrine tumour, among others.
Clinical trials run by this sponsor – those enrolling participants first.
FranceSpain
BelgiumFranceSpainSpainIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
